Literature DB >> 24148124

[microRNA: new diagnostic and therapeutic tools in liver disease?].

Angélique Gougelet1, Sabine Colnot.   

Abstract

microRNA are small non coding RNA, which negatively regulate the expression of their targets. Due to their various targets, miRNAs play a key role in number of physiological processes and in oncogenesis. The identification of specific miRNA signatures in various types of tumours, including hepatocellular carcinoma (HCC), highlights the dual role of miRNA, both oncogenes and tumour suppressors. Here, we review the current knowledge concerning the deregulation of miRNA expression in liver disease. All studies focusing on miRNAs argue for their possible use as diagnostic, prognostic and therapeutic markers. Here, we preferentially discuss the promising therapeutic strategies based on miRNAs that have been tested in HCC.
© 2013 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24148124     DOI: 10.1051/medsci/20132910013

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  6 in total

1.  MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells.

Authors:  Hong-Lei Jiang; Hao Yu; Xu Ma; Dong Xu; Guo-Fu Lin; Dong-Yan Ma; Jun-Zhe Jin
Journal:  Tumour Biol       Date:  2014-04-17

2.  Serum microRNAs as potential biomarkers of primary biliary cirrhosis.

Authors:  Youwen Tan; Tengli Pan; Yun Ye; Guohong Ge; Li Chen; Danfeng Wen; Shengqiang Zou
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

3.  A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease.

Authors:  Youwen Tan; Guohong Ge; Tengli Pan; Danfeng Wen; Jianhe Gan
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

Review 4.  Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.

Authors:  Sijia Shen; Yuxin Lin; Xuye Yuan; Li Shen; Jiajia Chen; Luonan Chen; Lei Qin; Bairong Shen
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

5.  Exosomal microRNAs as a potential therapeutic strategy in hepatocellular carcinoma.

Authors:  Angélique Gougelet
Journal:  World J Hepatol       Date:  2018-11-27

6.  MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review.

Authors:  Xiao-Yu Wei; Jing Ding; Wen-Guang Tian; Yi-Chuan Yu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.